A hospital discharge can feel like the end of a crisis. For many Medicare Advantage families, it is only the beginning of a new one.
Why the latest findings are so alarming
Fresh federal oversight has sharpened concerns about how Medicare Advantage plans handle requests for post-acute care. In 2026, the HHS Office of Inspector General reported that, among 19 Medicare Advantage organizations reviewed, the three largest insurers denied requests for long-term acute care hospitals and inpatient rehabilitation facilities at higher rates than most peers during June 2024. The agency said denials in this area are especially troubling because these settings serve patients recovering from major illness, injury, or complex hospitalization.
The headline numbers are stark. When patients and providers appealed denials for long-term acute care hospital stays, insurers collectively overturned 36% of those denials. For inpatient rehabilitation facility care, they overturned 43%. That means a substantial share of people were initially told no, only to have the insurer later reverse course.
The same OIG review found contractor behavior may be part of the problem. In some cases, outside companies handling prior authorization on behalf of insurers drove high denial rates, and many of those denials were later overturned by the plans themselves. That raises an uncomfortable question: whether the front end of the system is built to reject too much, too quickly.
These findings fit into a larger pattern. KFF reported that Medicare Advantage insurers processed nearly 53 million prior authorization requests in 2024 and denied 4.1 million of them, or 7.7%. Only 11.5% of denials were appealed, yet more than 80% of appealed denials were overturned, suggesting many patients face delays over care that is ultimately approved.
What “long-term care” means in this fight
The phrase “long-term care” can be misleading in this context. The federal reports largely focus on post-acute care following a hospital stay, including long-term acute care hospitals, inpatient rehabilitation facilities, and skilled nursing facilities. These are not elective comforts. They are often the bridge between an acute hospital stay and a safe return home.
A patient recovering from a stroke may need intensive rehab. Someone who has spent weeks in an ICU may require specialised respiratory treatment in a long-term acute care hospital. Another patient with a hip fracture may need a skilled nursing facility for therapy and nursing supervision before walking safely again. When authorization is denied, discharge planning can collapse overnight.
The OIG also released a separate 2026 report on skilled nursing facility admissions. There, the 19 Medicare Advantage organisations collectively denied 12% of requests in June 2024. Even more striking, when those denials were appealed, insurers overturned 95% of them in favor of the enrollee.
That 95% figure is hard to dismiss as routine administrative cleanup. It suggests that many families who push back eventually win, but only after time, paperwork, stress, and possible disruption in care. For older adults leaving the hospital, those delays can worsen recovery, increase caregiver burden, and heighten the risk of readmission.
How families end up staring at $49,000 bills
The financial damage from a denial can be immediate. If a family believes a loved one truly needs a rehab hospital, long-term acute care hospital, or skilled nursing facility, they may feel cornered into paying privately while an appeal drags on. Those settings are expensive, and a prolonged stay can quickly run into tens of thousands of dollars.
That is what makes stories of $49,000 bills so resonant. Even when the exact amount varies by market, length of stay, and type of facility, the basic math is believable because post-acute institutional care is among the costliest services older adults encounter. A few weeks of specialized inpatient care can easily create a bill that exceeds many retirees’ annual disposable income.
The issue is not only total cost but timing. Families are often forced to make decisions within hours of discharge. Pay privately, accept a lower level of care, or take a loved one home without enough support. None of those choices is truly voluntary when the patient is medically fragile and the insurer controls the approval.
Medicare Advantage plans often market lower premiums and extra benefits, which helps explain why KFF says 54% of Medicare beneficiaries, or 34.1 million people in 2025, are enrolled in Medicare Advantage rather than traditional Medicare. But those tradeoffs can become painfully clear when prior authorization stands between a patient and medically ordered recovery care.
Why appeals data may be the biggest warning sign
The most revealing numbers in this debate may not be the initial denial rates. They may be the overturn rates. Across Medicare Advantage broadly, KFF found that 80.7% of appealed prior authorization denials were partially or fully overturned in 2024. In skilled nursing facility cases reviewed by OIG, the overturn rate reached 95%.
On paper, insurers might argue that appeals are proof the system works. In practice, they can also indicate the first decision was too aggressive, too incomplete, or too detached from the treating clinician’s judgment. For a recovering patient, an approval that arrives late is not equivalent to an approval granted when needed.
The appeals process is also unevenly accessible. KFF found that only 11.5% of denied requests were appealed in 2024. Many beneficiaries are older, sick, cognitively impaired, or dependent on adult children already juggling jobs and caregiving. A family that cannot navigate forms, deadlines, and medical records may never challenge a wrongful denial at all.
That means the visible overturn rate may understate the harm. The people who appeal are only a fraction of those denied. If most of the few who do appeal eventually win, it raises serious concerns about the much larger group who simply give up, accept less care, or absorb the bill themselves.
What patients, regulators, and insurers do next
Regulators are now under pressure to treat these reports as more than isolated findings. The OIG has urged CMS to collect more detailed request-level prior authorization data, including information about service type and contractors, and to examine why denial and overturn rates vary so widely across plans. Better data will not solve the problem by itself, but it would make troubling patterns harder to hide.
CMS is already moving toward more detailed data collection. KFF reported that the agency is implementing a pilot to gather plan- and service-level prior authorization data, with broader expansion anticipated in 2027. That matters because aggregate figures can obscure whether certain services, such as rehab or skilled nursing, are where patients face the greatest friction.
For families, the practical lesson is blunt: a denial is not always the final word. Hospital case managers, treating physicians, and facility staff can be crucial in documenting medical necessity and pushing an appeal quickly. The federal data show that many initial denials do not hold up under review.
Still, the burden should not rest on exhausted relatives at a hospital bedside. When medically necessary post-acute care is delayed or denied, the cost is measured not just in dollars, but in lost recovery time, avoidable setbacks, and trust broken at the moment patients are most vulnerable.